Company · CIK 0001720725
Oyster Point Pharma, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- SC 13G/AOyster Point Pharma, Inc.0001104659-23-021891 · 62.2 KBSEC(opens sec.gov)
- SC 13G/AOyster Point Pharma, Inc.0000899140-23-000375 · 50.4 KBSEC(opens sec.gov)
- SC 13G/AOyster Point Pharma, Inc.0000902664-23-001714 · 61.7 KBSEC(opens sec.gov)
- 8-K/AOyster Point Pharma, Inc.0001193125-23-008477 · 226.7 KBSEC(opens sec.gov)
- SC 13D/AOyster Point Pharma, Inc.0001193125-23-008356 · 158.9 KBSEC(opens sec.gov)
- SC 13D/AOyster Point Pharma, Inc.0001072613-23-000017 · 98.6 KBSEC(opens sec.gov)
- SC 13D/AOyster Point Pharma, Inc.0001193125-23-002454 · 77.8 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-23-000324 · 321.9 KBSEC(opens sec.gov)
- SC 13D/AOyster Point Pharma, Inc.0001193125-22-309236 · 81.4 KBSEC(opens sec.gov)
- SC 13D/AOyster Point Pharma, Inc.0001072613-22-000647 · 459.9 KBSEC(opens sec.gov)
Insiders
Tickers
No tickers on record.
Addresses
business
202 CARNEGIE CENTER SUITE 106
PRINCETON, NJ, 08540
mailing
202 CARNEGIE CENTER SUITE 106
PRINCETON, NJ, 08540
Same industry
Related Biological Products, (No Diagnostic Substances) companies
- TBIO-TECHNE CorpTECH
- AAERIE PHARMACEUTICALS INC
- CCellular Biomedicine Group, Inc.
- TTourmaline Bio, Inc.TRML
- NNKGen Biotech, Inc.
- TTevogen Inc.TVGN
- AAttovia Therapeutics, Inc.ATTO
View all Biological Products, (No Diagnostic Substances) companies